HomeNRSN • NASDAQ
add
Neurosense Therapeutics Ltd
Previous close
$1.11
Day range
$1.00 - $1.12
Year range
$0.51 - $2.33
Market cap
24.01M USD
Avg Volume
418.86K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.11M | -27.27% |
Net income | -2.15M | -373.98% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.10M | 27.38% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 344.00K | -92.77% |
Total assets | 984.00K | -81.73% |
Total liabilities | 3.80M | -31.89% |
Total equity | -2.82M | — |
Shares outstanding | 19.81M | — |
Price to book | -7.93 | — |
Return on assets | -372.92% | — |
Return on capital | 235.89% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.15M | -373.98% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2017
Website
Employees
18
